Beneficiary Profile: The Florey

Every year, 4.7 million Australians are diagnosed with one of the conditions that the Florey study. That's why they believe everyone has a stake in medical research.

Beneficiary Profile: The Florey

July 7, 2020
Every year, 4.7 million Australians are diagnosed with one of the conditions that the Florey study. That's why they believe everyone has a stake in medical research.
Read Transcript

Every year, 4.7 million Australians are diagnosed with one of the conditions that the Florey Institute of Neuroscience and Mental Health (the Florey) study.  That’s why the Florey believes that everyone has a stake in health and medical research.

From mental health to epilepsy, stroke, dementia and basic discovery science, they are at the forefront of science's final frontier.

The Florey is the largest brain research group in the Southern Hemisphere and in the top 10 of the world’s best brain research centres.  In 1963, brothers Ken and Baillieu Myer, along with Ian Potter, worked with founding director, Derek Denton, to raise money to establish a medical research institute. This great act of philanthropy was the beginning of the Florey’s 55-year history and their connections to the community remain strong.

The Florey’s partnership with Hearts and Minds Investments Limited (HM1) is a testament to this wonderful collaborative spirit. As a celebrated member of the Florey Alumni community, Dr Mark Nelson is a former PhD student and lifelong Florey supporter. As Chair and Co-Founder of Caledonia Investments, Mark nominated the Florey as a beneficiary of HM1.

Today HM1 donates to the Florey encouraging the development of medicines and driving a new generation of medical research in Australia. The impact of this investment to the Florey's work is invaluable, as Mark notes, “Neuroscience is an area that the world really needs to focus on. Any investor will think very carefully about where they want their money to go. This initiative isn’t a band-aid. This aims at big ideas; at prevention and ways we can have far-reaching effects on human health. It’s almost at the stage that if we don’t fund brain research now and wait 20 years, we’ll look back and think ‘oh, that was a mistake. If only we’d done something at the time’.”

With thanks to Caledonia Investments and Hearts & Minds Investments Limited, Florey scientists continue to conduct important research in the area of brain and mind.

As part of our impact video series, we spoke with two key researchers at the Florey Institute for Neuroscience, discussing the importance of medical research and their recent breakthroughs. You can watch the video below.

Every year, 4.7 million Australians are diagnosed with one of the conditions that the Florey Institute of Neuroscience and Mental Health (the Florey) study.  That’s why the Florey believes that everyone has a stake in health and medical research.

From mental health to epilepsy, stroke, dementia and basic discovery science, they are at the forefront of science's final frontier.

The Florey is the largest brain research group in the Southern Hemisphere and in the top 10 of the world’s best brain research centres.  In 1963, brothers Ken and Baillieu Myer, along with Ian Potter, worked with founding director, Derek Denton, to raise money to establish a medical research institute. This great act of philanthropy was the beginning of the Florey’s 55-year history and their connections to the community remain strong.

The Florey’s partnership with Hearts and Minds Investments Limited (HM1) is a testament to this wonderful collaborative spirit. As a celebrated member of the Florey Alumni community, Dr Mark Nelson is a former PhD student and lifelong Florey supporter. As Chair and Co-Founder of Caledonia Investments, Mark nominated the Florey as a beneficiary of HM1.

Today HM1 donates to the Florey encouraging the development of medicines and driving a new generation of medical research in Australia. The impact of this investment to the Florey's work is invaluable, as Mark notes, “Neuroscience is an area that the world really needs to focus on. Any investor will think very carefully about where they want their money to go. This initiative isn’t a band-aid. This aims at big ideas; at prevention and ways we can have far-reaching effects on human health. It’s almost at the stage that if we don’t fund brain research now and wait 20 years, we’ll look back and think ‘oh, that was a mistake. If only we’d done something at the time’.”

With thanks to Caledonia Investments and Hearts & Minds Investments Limited, Florey scientists continue to conduct important research in the area of brain and mind.

As part of our impact video series, we spoke with two key researchers at the Florey Institute for Neuroscience, discussing the importance of medical research and their recent breakthroughs. You can watch the video below.

Disclaimer: This material has been prepared by The Florey, published on July 7, 2020. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
April 20, 2023

Artificial intelligence gives new hope for sufferers of severe heart problem

New AI software can improve the diagnosis of severe aortic stenosis by 72% and could potentially change the lives of about 50,000 Australians with the life-threatening condition.

Read More
February 14, 2023

Bringing Equity and Diversity to Genomic Medicine

Professor Daniel MacArthur, Director of the Centre for Population Genomics has big goals to bring equity and diversity into genomic medicine in Australia, something surprisingly inadequate presently.

Read More
September 6, 2022

VCCRI: 'Heart in a Box'

An Australian method of preserving donated hearts has boosted the number of successful transplants across the world, with new research demonstrating similar survival rates to traditional transplants.

Read More
February 24, 2022

Impact Video: Cerebral Palsy Alliance

This video features Professor Nadia Badawi AM, Professor Alistair McEwan, Paul Rayson and others discussing the incredible impact our partnership will have.

Read More
February 24, 2022

New Partnership with Cerebral Palsy Alliance

We’re excited to announce a new partnership with the Cerebral Palsy Alliance and are proud to be supporting this important research.

Read More
August 3, 2021

Australian breakthrough to stop heart arteries from clogging

Victor Chang scientist has led landmark research that has the potential to stop arteries of the heart from becoming clogged by targeting a particular gene.

Read More
October 12, 2020

Beneficiary Profile: Victor Chang

Cardiovascular disease is the number one cause of death globally and costs the Australian economy $12 billion each year. Every 12 minutes, one Australian dies from the disease. This is why the Victor Chang Cardiac Research Institute is dedicated to finding cures through their world class research.

Read More
September 23, 2020

Silent wave' of brain damage could follow pandemic

Australia urgently needs to prepare for a "silent wave" of COVID-19, which appears to be taking the form of long-term neurological side effects following infection with the virus.

Read More
September 8, 2020

Beneficiary Profile: Black Dog Institute

1 in 5 of us will experience symptoms of mental illness in any given year. In Australia that’s around 5 million people. And roughly 60% of these people won’t seek help. Learn what Black Dog is doing to create a mentally healthier world for everyone.

Read More
August 10, 2020

Beneficiary Profile: RPA Green Light

Emergency departments are the frontline of health care, with one in seven Australians seeking help from a hospital emergency department every year. Our medical staff depend on research findings to help inform their responses to urgent patient needs.

Read More
June 9, 2020

Beneficiary Profile: Orygen

1 in 5 young people will have experienced a depressive episode by the time they are 18. With thanks to Cooper Investors and Hearts & Minds, we have been able to put youth mental health on the global agenda and progress our work in developing a global mental health framework.

Read More
November 22, 2019

Impact Video Series: Sydney Children's Hospital Foundation

We interviewed leading individuals from our beneficiaries to discuss the importance of medical research, their recent breakthroughs and the vital need for private funding.

Read More
May 29, 2019

Winning Hearts and Minds

Mark Nelson of Caledonia discusses his connection with the Florey Institute, one of our beneficiaries, and why he's involved with Hearts and Minds.

Read More